GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » 5-Year Yield-on-Cost %

Basilea Pharmaceutica (XSWX:BSLN) 5-Year Yield-on-Cost % : 0.00 (As of May. 24, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica 5-Year Yield-on-Cost %?

Basilea Pharmaceutica's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Basilea Pharmaceutica's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Basilea Pharmaceutica's highest Yield on Cost was 5.95. The lowest was 0.00. And the median was 5.01.


XSWX:BSLN's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.73
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Basilea Pharmaceutica's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Basilea Pharmaceutica's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Basilea Pharmaceutica's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Basilea Pharmaceutica's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Basilea Pharmaceutica's 5-Year Yield-on-Cost % falls into.



Basilea Pharmaceutica 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Basilea Pharmaceutica is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Basilea Pharmaceutica  (XSWX:BSLN) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Basilea Pharmaceutica 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Basilea Pharmaceutica (XSWX:BSLN) Business Description

Traded in Other Exchanges
Address
Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (XSWX:BSLN) Headlines

No Headlines